TrialAntiviral research2009

Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: current state of the art.

Karl Y HostetlerPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.